Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

por Telliam, Gladys, Desterke, Christophe, Imeri, Jusuf, M’kacher, Radhia, Oudrhiri, Noufissa, Balducci, Estelle, Fontaine-Arnoux, Micheline, Acloque, Hervé, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Publicado 2023

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)

por Imeri, Jusuf, Desterke, Christophe, Marcoux, Paul, Telliam, Gladys, Sanekli, Safa, Barreau, Sylvain, Erbilgin, Yucel, Latsis, Theodoros, Hugues, Patricia, Sorel, Nathalie, Cayssials, Emilie, Chomel, Jean-Claude, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Publicado 2023

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

por Gentil, Melanie, Hugues, Patricia, Desterke, Christophe, Telliam, Gladys, Sloma, Ivan, Souza, Lucas E. B., Baykal, Seda, Artus, Jerome, Griscelli, Frank, Guerci, Agnes, Johnson-Ansah, Hyacinthe, Foudi, Adlen, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Publicado 2018